Domov › Rak jajčnikov › Colorado
Klinične študije za Rak jajčnikov v Colorado
44 študij za Rak jajčnikov išče udeležence na lokacijah v Colorado.
Mesta v Colorado
- Aurora25 študij
- Denver16 študij
- Highlands Ranch5 študij
- Fort Collins5 študij
- Boulder4 študij
- Greeley4 študij
- Loveland4 študij
Uradno besedilo študije (angleško)
The Vanguard Study: Testing a New Way to Screen for Cancer
- Keefe Memorial Hospital, Cheyenne Wells
- Kaiser Permanente-Franklin, Denver
- Poudre Valley Hospital, Fort Collins
- in še 5
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 45–75 · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT06995898Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
- UCHealth University of Colorado Hospital, Aurora
Vključevanje udeležencevFaza 2/3
Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT07001748Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- UCHealth University of Colorado Hospital, Aurora
- Poudre Valley Hospital, Fort Collins
- Cancer Care and Hematology-Fort Collins, Fort Collins
- in še 2
Vključevanje udeležencevFaza 2
Vse starosti · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT05564377Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- Research Site, Aurora
Vključevanje udeležencevFaza 1/2
Starost 18–130 · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT05797168A Study of PHST001 in Advanced Solid Tumors
- Sarah Cannon Research Institute (SCRI) Oncology Partners - Denver Health One, Denver
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT06840886A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Sarah Cannon Research Institute at HealthOne, Denver
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06465069The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Rocky Mountain Cancer Center, Denver
Vključevanje udeležencevFaza 1/2
Starost 12 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04585750A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- SCRI at HealthOne, Denver
Vključevanje udeležencevFaza 1
Starost 19 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06586957A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- University of Colorado Hospital- Aurora /ID# 278232, Aurora
Vključevanje udeležencevFaza 2
Starost 18 in več · Ženske · Posodobljeno 1. okt. 2026 · NCT07024784A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
- Sarah Cannon Research Institute at HealthONE /ID# 278785, Denver
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07278336First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
- University of Colorado Denver, Aurora
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT06799065A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Site 0135 - Rocky Mountain Cancer Centers, Lone Tree
Vključevanje udeležencevFaza 2
Starost 18 in več · Ženske · Posodobljeno 29. sep. 2026 · NCT05128825DESTINY-PANTUMOUR04
- Research Site, Boulder
Vključevanje udeležencevOpazovalna študija
Starost 18–130 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07124000A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Anschutz Cancer Pavilion, Aurora
- AdventHealth Medical Group - Porter, Denver
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07213804Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- University of Colorado Cancer Center, Aurora
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06128551Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- University of Colorado Cancer Center, Aurora
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT05983432Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- University of Colorado Cancer Center, Aurora
Vključevanje udeležencevFaza 3
Starost 18 in več · Ženske · Posodobljeno 15. sep. 2026 · NCT07214779ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- University of Colorado, Aurora
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT05059444Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
- Outpatient CTRC, Aurora
- University of Colorado Cancer Center, Aurora
Vključevanje udeležencevFaza 1
Starost 21 in več · Ženske · Posodobljeno 4. sep. 2026 · NCT06430541A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
- SCRI at HCA Health One, Denver
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 27. avg. 2026 · NCT07186842Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- Sarah Cannon Research Institute - Denver DDU, Denver
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 27. avg. 2026 · NCT06582017Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Hospital Colorado, Aurora
Vključevanje udeležencevFaza 1/2
12 Months – 30 Years · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT04851119A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Denver
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT07182149A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- UCHealth University of Colorado Hospital, Aurora
- UCHealth Memorial Hospital Central, Colorado Springs
- Memorial Hospital North, Colorado Springs
- in še 5
Vključevanje udeležencev
Starost 35–50 · Ženske · Posodobljeno 7. avg. 2026 · NCT04251052Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- UCHealth University of Colorado Hospital, Aurora
- Intermountain Health Platte Valley Hospital, Brighton
- Penrose-Saint Francis Healthcare, Colorado Springs
- in še 21
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT06580314A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Rocky Mountain Cancer Center, Denver
- Sarah Cannon Research Institute at HealthONE, Denver
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 30. jul. 2026 · NCT04657068Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer
- CU Medicine Clinics, Aurora
- Universtiy of Colorado Hospital, Aurora
Vključevanje udeležencevFaza 1
Starost 18 in več · Ženske · Posodobljeno 24. jul. 2026 · NCT06856499An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
- University of Colorado Hospital, Aurora
Vključevanje udeležencevFaza 2
Starost 18–100 · Ženske · Posodobljeno 13. jul. 2026 · NCT05887609A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
- Rocky Mountain Cancer Center, Littleton
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 10. jul. 2026 · NCT06695845First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- University of Colorado Cancer Center, Aurora
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 7. jul. 2026 · NCT05768139Integrated Cancer Repository for Cancer Research
- Advent Health, Greenwood Village
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 19–110 · Vsi spoli · Posodobljeno 29. jun. 2026 · NCT02012699The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer
- University of Colorado Anschutz Medical Campus, Aurora
- University of Colorado Boulder, Boulder
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 9. jun. 2026 · NCT07636200JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation
- Research Site, Denver
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 22. maj 2026 · NCT06386146DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- USA01-0, Wheat Ridge
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 22. maj 2026 · NCT06953089ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- University of Colorado, Anschutz Medical Campus, Aurora
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 13. maj 2026 · NCT03686124Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
- University of Colorado Hospital - Anshutz Cancer Pavilion, Aurora
Vključevanje udeležencevFaza 3
Starost 18 in več · Ženske · Posodobljeno 16. apr. 2026 · NCT05659381REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
- University of Colorado Cancer Center-Anschutz, Aurora
- University of Colorado Boulder, Boulder
Vključevanje udeležencev
Starost 18 in več · Ženske · Posodobljeno 13. apr. 2026 · NCT06710548A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
- Site 0264, Aurora
Vključevanje udeležencevFaza 1
Starost 18 in več · Ženske · Posodobljeno 7. apr. 2026 · NCT04516447Survivors Uniting for Remote Guided Exercise
- Human Performance Clinical Research Lab, Fort Collins
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 31. mar. 2026 · NCT07290309Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis
- University of Colorado Cancer Center, Aurora
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 2. feb. 2026 · NCT07030283Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.